United States · 
What does Biotechnology Value Fund invest in?
Biotechnology Value Fund invests most often at Series A and Series B (67% of the rounds on record), in sectors such as Health Care and Internet.
Biotechnology Value Fund highlights
- 01
6 rounds on record
- 02
Mostly Series A and Series B: 67% of its rounds
- 03
Sole investor in 1 rounds, median $40M
What they do
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries A
- Sectors
- Health CareInternet
- Based in
- San Francisco, United States
- Cold pitches
- Not stated
A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. Tell us the right one.
The record
Every round we can evidence, newest first6 appearances
- 2020
1 round
- Mar
- 2014
1 round
- Jan
- 2013
1 round
- Sept
- 2012
1 round
- Nov
- 2004
1 round
- Mar
- 2003
1 round
- Jan
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration3 named
JGJames Geoffrey KratkyChief Financial Officer, Chief Compliance OfficeriForm ADV
JRJason Robert MccuneChief Operating OfficeriForm ADV
MNMark Nathan LampertChief Executive OfficeriForm ADV
We also hold 5 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$6.1Bassets it managesOct 2026
Registeredinvestment adviserfull reporting to the SEC
- Legal name
- BVF Partners L.P.
- SEC number
- CRD 156149
Funds on its Form ADV
4 private funds, $6.1B in gross assets · filed Mar 2024
- Biotechnology Value Fund, L.P.Hedge83 investors$3.2B
- Biotechnology Value Fund II, L.P.Hedge121 investors$2.5B
- Biotechnology Value Trading Fund OS L.P.Hedge4 investors$323M
- BVF Investments, LLCHedge2 investors$580K